Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
7.00
-0.05 (-0.71%)
At close: Aug 1, 2025

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 1.21B NGN in the quarter ending March 31, 2025, with 86.08% growth. This brings the company's revenue in the last twelve months to 5.04B, up 111.09% year-over-year. In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B with 102.98% growth.

Revenue (ttm)
5.04B
Revenue Growth
+111.09%
P/S Ratio
5.93
Revenue / Employee
25.73M
Employees
196
Market Cap
29.91B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20244.49B2.28B102.98%
Dec 31, 20232.21B-709.73M-24.31%
Dec 31, 20222.92B216.47M8.01%
Sep 30, 20222.70B-343.81M-11.28%
Sep 30, 20213.05B207.54M7.31%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MTN Nigeria Communications4,201.09B
Dangote Cement3,892.09B
BUA Foods1,768.04B
BUA Cement1,092.83B
Zenith Bank2,315.03B
Geregu Power144.08B
Guaranty Trust Holding Company1,483.40B
Lafarge Africa918.16B
Revenue Rankings